Effect of luminal atrial natriuretic peptide on chloride reabsorption in mouse cortical thick ascending limb: Inhibition by endothelin

Journal of the American Society of Nephrology

Volumn 11, Issue 10, 2000, Pages 1791-1797

  Bailly, Claire ^a  

^a CEA SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BISINDOLYLMALEIMIDE; CHLORIDE; CYCLIC GMP; ENDOTHELIN; GUANYLATE CYCLASE; PROTEIN KINASE C INHIBITOR;

ABSORPTION; ANIMAL CELL; ARTICLE; CHLORIDE BLOOD LEVEL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HENLE LOOP; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SODIUM ABSORPTION; URINARY EXCRETION;

EID: 0033770677     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Maack T: Role of atrial natriuretic factor in volume control. Kidney Int 49: 1732-1737, 1996
2. Nonoguchi H, Sands JM, Knepper MA: ANF inhibits NaCl and fluid absorption in cortical collecting duct of rat kidney. Am J Physiol 256: F179-F186, 1989
3. Rocha AS, Kudo LH: Atrial peptide and cGMP effects on NaCl transport in inner medullary collecting duct. Am J Physiol 259: F258-F268, 1990
4. Sonnenberg H, Honrath U, Wilson DR: In vivo microperfusion of inner medullary collecting duct in rats: Effect of amiloride and ANF. Am J Physiol 259: F222-F226, 1990
5. Nonoguchi H, Tomita K, Marumo F: Effects of atrial natriuretic peptide and vasopressin on chloride transport in long- and short-looped medullary thick ascending limbs. J Clin Invest 90: 349-357, 1992
6. Néant F, Bailly C: Luminal and intracellular cGMP inhibits the mTAL reabsorptive capacity through different pathways. Kidney Int 44: 741-746, 1993
7. Margulies KB, Cavero PG, Seymour AA, Delaney NG, Burnett JC: Neutral endopeptidase inhibition potentiates the renal actions of atrial natriuretic factor. Kidney Int 38: 67-72, 1990
8. Pham I, Gonzalez W, El Amrani AIK, Fournié-Zaluski MC, Philippe M, Laboulandine I, Roques BP, Michel JB: Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension. J Pharmacol Exp Ther 265: 1339-134, 1993
9. Wilkins MR, Settle SL, Stockmann PT, Needleman P: Maximizing the natriuretic effect of endogenous atriopeptin in a rat model of heart failure. Proc Natl Acad Sci USA 87: 6465-6469, 1990
10. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML: Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70: 665-699, 1990
11. de Jesus Ferreira MC, Bailly C: Luminal and basolateral endothelin inhibit chloride reabsorption in the mouse thick ascending limb via a Ca-independent pathway. J Physiol (London) 505: 749-758, 1997
12. Sokolovsky M, Galron R, Kloog Y, Bdolah A, Indig FE, Blumberg S, Fleminger G: Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: Possible physiological significance. Proc Natl Acad Sci USA 87: 4702-4706, 1990
13. Di Stefano A, Greger R, de Rouffignac C, Wittner M: Active NaCl transport in the cortical thick ascending limb of Henle's loop of the mouse does not require the presence of bicarbonate. Pflügers Arch 420: 290-296, 1992
14. Matsuda Y, Morishita Y: HS-142-1: A novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. Cardiovasc Drug Rev 11: 45-59, 1993
15. Nonoguchi H, Knepper MA, Manganiello VC: Effects of atrial natriuretic factor on cyclic guanosine monophosphate and cyclic adenosine monophosphate accumulation in microdissected nephron segments from rats. J Clin Invest 79: 500-507, 1987